|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Washington University School of Medicine and the Lung Transplantation Program, Barnes-Jewish Hospital, St. Louis
In appropriately selected patients with COPD and
-antitrypsin deficiency emphysema, lung transplantation prolongs life, improves functional capacity, and enhances quality of life. However, rejection remains an obstacle to better medium-term results, and lung transplantation is a treatment, not a cure and not a panacea.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |